Navigation Links
TRICAST Launches New Version of Web-Based Pharmacy Benefits Surveillance and Analytics Software Tool
Date:8/14/2014

MILWAUKEE, Aug. 14, 2014 /PRNewswire/ -- TRICAST, Inc. today announced the availability of Reveal™ 2.0, its cutting-edge web-based software tool that leverages nearly two decades' worth of prescription drug benefit consulting expertise.

"We've baked all our knowledge into a product that delivers real-time surveillance and analytics (both retrospective and predictive) for comprehensive pharmacy benefit oversight. There's really nothing else like it in our industry," said TRICAST President Greg Rucinski.

The release of Reveal also marks TRICAST's entry into the software as a service (SaaS) market space. SaaS is a software and licensing delivery model in which the software is licensed on a subscription basis and is centrally hosted.

"Applying a SaaS model in the healthcare industry has the potential to significantly reduce our client's IT support costs as well as allowing Reveal™ to grow with the client without incurring additional IT capital expenditures," noted Director of Infrastructure Chris Favero.

Reveal enables TRICAST clients to monitor pricing, process, and formulary and rebate adherence. The tool also includes a full suite of Centers for Medicare & Medicaid Services (CMS) oversight products such as automated reject analysis, comparisons of source to PDE claims, and all other CMS oversight requirements.

"We've learned a lot about what's important to the healthcare marketplace in our two decades of consulting and we've built it into Reveal," said Director of Software Development Ken Ullsperger.

For example, many need an automated method of importing data that's integrated with fixed files such as Medi-Span® or First DataBank® pharmaceutical information, CMS watch list criteria, CMS gap discount information, taxonomy files, and other decision-support information.

"We want to be very clear: TRICAST is not abandoning our tried and true consulting offerings. What it really means is that we are empowering our clients by harnessing the benefits of our fifteen years of experience and making it available to them," concluded Rucinski. "Our Reveal clients benefit because their pharmacy benefit data is available for comparative analysis at a daily, hourly and even down to the minute frequency. Our Reveal clients can now focus on the road ahead instead of looking back at what has already transpired."

About TRICAST

TRICAST is a pharmacy data analytics company utilizing industry expertise and powerful software tools to empower our clients to make decisions that lower their healthcare costs and efficiently manage their pharmacy benefit programs. TRICAST is headquartered in Milwaukee, Wisconsin. We serve clients nationwide.

Media Contact

Rob Shelley, Senior VP of Business Development
612-940-6390
Email


'/>"/>
SOURCE TRICAST
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. TRICAST Announces Patent-Pending Technology for Real-Time Health Data Analysis
2. TRICAST Hosts Annual Round Table Assessment of Mid-Market Pharmacy Benefit Managers, Specialty Providers
3. TRICAST Debuts Part D Rejection Oversight Solution for Drug Plan Sponsors
4. Marijuana Connect Launches in the Spectacular Summer of 2014!
5. NCPA Launches Any Willing Pharmacy Campaign During August Congressional Recess
6. Z Trim Launches Food-Grade Biofiber Gum
7. OSTAR Launches Its A Series Cloud Based Telehealth Vital Signs Patient Monitoring System
8. Janssen Launches Online Healthy Minds Video Series
9. AARC Launches Virtual Museum
10. CPhI South America 2014 Launches with Generics Showing Huge Growth
11. Restore Health Launches Pharmacogenetic Testing, Enhancing Its Suite of Personalized Medicine Goods and Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... NEW YORK , April 19, 2017 Cardiology ... during the projected period The Cardiology Devices segment ... more than US$ 15 Mn in 2018 over 2017. By ... reach a market valuation close to US$ 700 Mn, expanding ... Cardiology Devices segment dominated the Asia Pacific ...
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... N.J. , April 19, 2017  Novartis ... by the National Heart, Lung, and Blood Institute ... demonstrating that 58% of patients with treatment-naïve severe ... months when treated with eltrombopag at the initiation ... . The study evaluated three sequential treatment groups, ...
Breaking Medicine Technology:
(Date:4/25/2017)... ... April 25, 2017 , ... ProRehab Physical ... be the preferred physical therapy provider for Derby City CrossFit, effective immediately. , ... CrossFit as quickly and effectively as possible, ProRehab’s sports physical therapists will work ...
(Date:4/25/2017)... ... April 25, 2017 , ... A recent report from ... performance for the 2015-16 school year across Wisconsin’s public schools, charter schools, and ... important patterns in student test score performance, the report’s limited analyses fail to ...
(Date:4/25/2017)... ... April 25, 2017 , ... As ... contracted partners to help with process innovation in drug formulation and manufacturing. ... along with state-of-the-art analytical equipment in support of their development and manufacturing goals. ...
(Date:4/25/2017)... ... 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality of spine ... focus on preventative care with all my patients to alleviate possible future issues. I am ... to contact my office and my trained staff will assist you in any way possible.” ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... healthcare products, is introducing Flexadin UCII, part of the EQUISTRO line, at this ... joint health in horses at the immunologic level. , The scientifically-developed Flexadin UCII ...
Breaking Medicine News(10 mins):